{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:26:46Z","timestamp":1786768006462,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.msard.2021.103190","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:54:28Z","timestamp":1627905268000},"page":"103190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK"],"prefix":"10.1016","volume":"55","author":[{"given":"Linford","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-8747","authenticated-orcid":false,"given":"Christopher Martin","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Tallantyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Chataway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Abuown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarunya","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Brittain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Djoukhadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Elsaddig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Fisniku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Franzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Galea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hardwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lammey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Mazibrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mubarak","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Paling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Petheram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schmierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cord","family":"Spilker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Thouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Wynford-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadas","family":"Zuromskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.103190_bib0001","unstructured":"BIOGEN, 2020. Physician Information and Management Guidelines for Patients With Multiple Sclerosis Receiving TYSABRI Therapy (Version 18)."},{"key":"10.1016\/j.msard.2021.103190_bib0002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.62.2.226","article-title":"Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination","volume":"62","author":"Bot","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103190_bib0003","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/brain\/awz156","article-title":"Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis","volume":"142","author":"Brownlee","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.103190_bib0004","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12883-016-0699-8","article-title":"MRI utility in the detection of disease activity in clinically stable patients with multiple sclerosis: a retrospective analysis of a community based cohort","volume":"16","author":"Cohan","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0005","unstructured":"Consortium of MS centres, 2018. Revised Guidelines of the Consortium of MS Centers MRI Protocol for the Diagnosis and Follow-up of MS."},{"key":"10.1016\/j.msard.2021.103190_bib0006","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000046587.83503.1E","article-title":"MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals","volume":"60","author":"Cotton","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103190_bib0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacr.2017.06.030","article-title":"Computer-aided detection can bridge the skill gap in multiple sclerosis monitoring","volume":"15","author":"Dahan","year":"2018","journal-title":"J. Am. Coll. Radiol."},{"key":"10.1016\/j.msard.2021.103190_bib0008","unstructured":"Fernandes, L., Allen, C.M., Williams, T., Tallantyre, E., Evangelou, N., Chataway, J., Ford, H., 2021. A multicentre audit on the use of MRI in the monitoring and management of people with Multiple Sclerosis [WWW Document]. URL https:\/\/www.institutemh.org.uk\/research\/nottingham-ms-research-group\/publications (accessed 7.14.21)."},{"key":"10.1016\/j.msard.2021.103190_bib0009","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jmri.25625","article-title":"Gadolinium-based contrast agents: a comprehensive risk assessment","volume":"46","author":"Fraum","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.msard.2021.103190_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2015.04.006","article-title":"Is it time to target no evident disease activity (NEDA) in multiple sclerosis?","author":"Giovannoni","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.103190_bib0012","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fneur.2019.00788","article-title":"Prospective assessment of no evidence of disease activity-4 status in early disease stages of multiple sclerosis in routine clinical practice","volume":"10","author":"Guevara","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnmol.2018.00335","article-title":"Gadolinium deposition in brain: current scientific evidence and future perspectives","volume":"11","author":"Guo","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.msard.2021.103190_bib0014","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3174\/ajnr.A5209","article-title":"The use of noncontrast quantitative MRI to detect gadolinium-enhancing multiple sclerosis brain lesions: a systematic review and meta-analysis","volume":"38","author":"Gupta","year":"2017","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2021.103190_bib0015","first-page":"117","article-title":"Stratification and monitoring of natalizumabassociated progressive multifocal leukoencephalopathy risk: recommendations from an expert group","volume":"87","author":"McGuigan","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2021.103190_bib0016","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/116.5.1077","article-title":"Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis","volume":"116","author":"Miller","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.103190_bib0017","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21958","article-title":"Long-interval T2w subtraction MRI: a powerful new outcome measure in MS trials","volume":"67","author":"Moraal","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0018","series-title":"Final Appraisal document: 1 | Siponimod for Treating Secondary Progressive Multiple Sclerosis | Guidance","year":"2020"},{"key":"10.1016\/j.msard.2021.103190_bib0019","series-title":"Overview | Ocrelizumab for Treating Primary Progressive Multiple Sclerosis | Guidance","year":"2019"},{"key":"10.1016\/j.msard.2021.103190_bib0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.0b013e31820d8b1d","article-title":"Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome","volume":"76","author":"Okuda","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103190_bib0021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/1352458509104591","article-title":"Measures in the first year of therapy predict the response to interferon \u03b2 in MS","volume":"15","author":"R\u00edo","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.103190_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrneurol.2015.106","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2014Establishing disease prognosis and monitoring patients","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0023","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0024","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ana.20883","article-title":"Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study","volume":"60","author":"Rudick","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0025","first-page":"1476","article-title":"Comparison of unenhanced and gadolinium-enhanced imaging in multiple sclerosis: is contrast needed for routine follow-up MRI?","author":"Sadigh","year":"2019","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2021.103190_bib0026","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7224\/1537-2073.2020-094","article-title":"An international standardized magnetic resonance imaging protocol for diagnosis and follow-up of patients with multiple sclerosis","volume":"22","author":"Saslow","year":"2020","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2021.103190_bib0027","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180926","article-title":"Commentary: towards a standard MRI protocol for multiple sclerosis across the UK","author":"Schmierer","year":"2019","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.msard.2021.103190_bib0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s004150170229","article-title":"A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis","volume":"248","author":"Silver","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0029","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1191\/1352458504ms1055oa","article-title":"Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study","volume":"10","author":"Stevenson","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.103190_bib0030","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2021.103190_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/WNL.46.2.373","article-title":"Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis","volume":"46","author":"Thorpe","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103190_bib0032","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00415-020-09930-0","article-title":"Diagnosis and management of multiple sclerosis: MRI in clinical practice","volume":"267","author":"Tomassini","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0033","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A4539","article-title":"Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis","author":"Traboulsee","year":"2016","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2021.103190_bib0034","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3174\/ajnr.A5185","article-title":"Neuroradiologists compared with non-neuroradiologists in the detection of new multiple sclerosis plaques","volume":"38","author":"Wang","year":"2017","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2021.103190_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0036","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2021.103190_bib0037","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/1352458515599246","article-title":"Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis","volume":"22","author":"Zecca","year":"2016","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821004570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821004570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:32:09Z","timestamp":1786764729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821004570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":37,"alternative-id":["S2211034821004570"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103190","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103190"}}